hemeonclinx Medical News about differentiating hepaocellular carcinoma from metastatic carcinoma;Role of CD10 immunochemistry

Email This Article

Save in My Library

Free Abstract

Ahuja A et al. – CD10 immunostaining is useful to discriminate hepatocellular carcinoma (HCC) and metastatic carcinoma of the liver and is easily applied on cell blocks as well as fine needle aspiration cytology (FNAC) smears

Methods

Study of the value of CD10 immunostain in distinguishing HCC from metastatic carcinoma in material from FNAC of liver masses

Immunostain with monoclonal antibody against CD10 for formalin-fixed, paraffin-embedded cell blocks of 22 cas

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 08/07/08

Antibiotic use predicts an increased risk of cancer
International Journal of Cancer, 08/20/08

Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women
Cancer Epidemiology, Biomarkers & Prevention, 08/21/08

...All of Basic Science/Genetics

Sponsor

--- HEPATOBILIARY/PANCREAS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Liver surgery for colorectal metastases: results after 10 years of follow-up. long-term survivors, late recurrences, and prognostic role of morbidity
Annals of Surgical Oncology, 09/17/08

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
Hepatology, 09/02/08

Surgery for gallbladder cancer: A population-based analysis
Journal of the American College of Surgeons, 08/18/08

...All of Hepatobiliary/Pancreas